Arkolith/Insider Trading/TNGX/Form 4

Rothenberg Mace

DirectorTango Therapeutics, Inc. (TNGX) · full profile →Form 4 · filed Nov 18, 2024
Net Buying
Open-Market Buys
$74K
Open-Market Sells
$0
Net Open-Market Flow
$74K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 18, 2024Buy(P)10K$3.78$38K31K
Nov 14, 2024Buy(P)10K$3.62$36K21K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-128163) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML